Insilico Medicine nabs $200 million AI-powered drug discovery deal

(Image credit: Pixabay/Arek Socha) Creators of a new machine-learning drug discovery platform Insilico Medicine has inked a dual-program drug discovery deal with Jiangsu Chia Tai Fenghai Pharmaceutical (CTFH) worth up to $200 million. Why it matters: The partnership is an additional sign of confidence in Insilico’s artificial intelligence (AI) technology following a $37 million Series B…

Ping An Technology AI predicts flu outbreaks with 90% accuracy

Ping An Technology’s intelligent disease prediction and screening models can now forecast the likelihood of an influenza outbreak with a more than 90% accuracy, according to a South China Morning Post report.  Why it matters: Accurate and timely predictions of infectious disease outbreaks can be valuable to authorities working to prevent and control them more efficiently—ultimately saving…

Study shows AI potential to drastically speed drug development in China

A study by Hong Kong-based Insilico Medicine utilized a new AI system that created a series of novel molecules capable of treating fibrosis and other illnesses on a significantly shorter timeline, the South China Morning Post reported.  Why it matters: Insilico used AI to identify treatment candidates in just three weeks compared with the traditional drug discovery process, which can take…